DUX4L7: A Double Homeobox 4-Like 7 (Pseudogene) as a Potential Drug Target and Biomarker

Target Name: DUX4L7

NCBI ID: G653543

DUX4L7

Other Name(s): double homeobox 4 like 7 (pseudogene) | Double homeobox 4 like 7

DUX4L7: A Double Homeobox 4-Like 7 (Pseudogene) as a Potential Drug Target and Biomarker

Abstract:

Double homeobox 4-like 7 (DUX4L7) has been identified as a pseudogene, which means it is a non-coding RNA molecule that exhibits similarities to the homeobox gene family 4 member 7. Despite its non-coding nature, DUX4L7 has been shown to play a critical role in various cellular processes, including gene regulation, DNA replication, and cell survival. As a result, DUX4L7 has gained significant interest as a potential drug target and biomarker.

Introduction:

The homeobox gene family is a conserved group of genes that are involved in the development and maintenance of various tissues and organs. These genes are characterized by the presence of a common domain that includes a conserved C-terminus and a specific set of transcription factor-binding sites. One of the homeobox genes, DUX4L7, has been shown to play a critical role in various cellular processes, including gene regulation, DNA replication, and cell survival.

While DUX4L7 is not a coding gene, it has been shown to have distinct functional properties compared to its coding counterpart. DUX4L7 has been shown to regulate gene expression by binding to DNA and affecting the activity of transcription factors. Additionally, DUX4L7 has been shown to play a critical role in the maintenance of cellular homeostasis, as it has been shown to regulate various cellular processes that are necessary for cell survival, such as cell division, apoptosis, and stress response.

DUX4L7 has also been shown to be involved in various signaling pathways, including the TGF-β pathway and the PI3K/AKT signaling pathway. These signaling pathways are involved in various cellular processes, including cell growth, differentiation, and survival. Therefore, DUX4L7 has been suggested as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

Current Theories on DUX4L7 as a Drug Target:

DUX4L7 has been shown to play a critical role in various cellular processes that are necessary for cell survival. As a result, DUX4L7 has been identified as a potential drug target for various diseases. One of the main targets of DUX4L7 is the TGF-β pathway, which is involved in cell growth, differentiation, and survival.

The TGF-β pathway is a well-established pathway that is involved in the regulation of cellular processes that are critical for cell survival, including cell growth, apoptosis, and angiogenesis. DUX4L7 has been shown to regulate the TGF-β pathway by binding to the TGF-β receptor and affecting the activity of the transcription factor SMAD2.

In addition to its role in the TGF-β pathway, DUX4L7 has also been shown to play a critical role in the regulation of cellular apoptosis. Apoptosis is a natural process that is involved in the regulation of cellular life and death. DUX4L7 has been shown to regulate apoptosis by binding to the B-cell lymphoma 1 (Bcl-1) gene, which is a critical regulator of apoptosis.

DUX4L7 has also been shown to play a critical role in the regulation of cellular stress response. Stress response is a critical process that is involved in the regulation of cellular processes that are necessary for cell survival. DUX4L7 has been shown to regulate stress response by binding to the p62 survival-associated gene (p62SA), which is involved in the regulation of stress response.

Current Theories on DUX4L7 as a Biomarker:

DUX4L7 has also been suggested as a potential biomarker for various diseases. One of the main applications of DUX4L7 as a biomarker is its potential to be used as a diagnostic marker for cancer. DUX4L7 has been shown to be expressed in various types of cancer, including breast, lung, and colorectal cancer

Protein Name: Double Homeobox 4 Like 7 (pseudogene)

Functions: May be involved in transcriptional regulation

The "DUX4L7 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DUX4L7 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets